The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression

被引:38
作者
Bellani, Marcella [1 ]
Dusi, Nicola [1 ]
Yeh, Ping-Hong [2 ]
Soares, Jair C. [3 ]
Brambilla, Paolo [4 ,5 ]
机构
[1] Univ Univ Verona, Dept Publ Hlth & Community Med, Sect Psychiat & Clin Psychol, Interuniv Ctr Behav Neurosci ICBN, Verona, Italy
[2] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA
[3] Univ Texas Houston, Sch Med, Dept Psychiat & Behav Sci, Houston, TX USA
[4] Univ Udine, DPMSC, Sect Psychiat, Interuniv Ctr Behav Neurosci ICBN, I-33100 Udine, Italy
[5] Sci Inst E Medea, Udine, Italy
关键词
MRI; MRS; PET; Serotonin; SPECT; MAGNETIC-RESONANCE-SPECTROSCOPY; SEROTONIN REUPTAKE INHIBITORS; REGIONAL CEREBRAL METABOLISM; POSITRON-EMISSION-TOMOGRAPHY; GAMMA-AMINOBUTYRIC-ACID; BLOOD-FLOW CHANGES; GLUCOSE-METABOLISM; HEALTHY-VOLUNTEERS; HIPPOCAMPAL VOLUME; ANATOMICAL MRI;
D O I
10.1016/j.pnpbp.2010.11.040
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent brain imaging studies have shed light on understanding the pathogenesis of mood disorders. Evidence of structural, chemical, and functional brain changes, particularly in prefrontal cortex, cingulate, and amygdala, has been revealed in major depressive disorder (MOD). Furthermore, imaging techniques have been applied to monitor the effects of antidepressants (ADS) both in the brains of healthy volunteers and MDD patients. Although with some discrepancies due to the differences in study designs and patient samples, imaging findings have shown that ADs, particularly those having effects on the serotonergic system, modulate the volumes, functions and biochemistry of brain structures, i.e. dorsolateral prefrontal cortex, anterior cingulate and amygdala, which have been demonstrated abnormal in MOD by earlier imaging studies. This paper reviews imaging studies conducted in MOD patients and healthy controls treated with different ADs. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:1544 / 1552
页数:9
相关论文
共 125 条
[1]   POSITRON EMISSION TOMOGRAPHY IMAGING OF REGIONAL CEREBRAL GLUCOSE-METABOLISM [J].
ALAVI, A ;
DANN, R ;
CHAWLUK, J ;
ALAVI, J ;
KUSHNER, M ;
REIVICH, M .
SEMINARS IN NUCLEAR MEDICINE, 1986, 16 (01) :2-34
[2]   Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study [J].
Anderson, Ian M. ;
Del-Ben, Cristina M. ;
Mckie, Shane ;
Richardson, Paul ;
Williams, Stephen R. ;
Elliott, Rebecca ;
Deakin, J. F. William .
NEUROREPORT, 2007, 18 (13) :1351-1355
[3]   Escitalopram effects on insula and amygdala BOLD activation during emotional processing [J].
Arce, Estibaliz ;
Simmons, Alan N. ;
Lovero, Kathryn L. ;
Stein, Murray B. ;
Paulus, Martin P. .
PSYCHOPHARMACOLOGY, 2008, 196 (04) :661-672
[4]  
BEARDEN CE, 2009, ASN NEURO, P1
[5]  
Bellani M, 2010, EPIDEMIOL PSICHIAT S, V19, P23
[6]  
Benedetti F, 2009, ARCH ITAL BIOL, V147, P83
[7]   Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor [J].
Bhagwagar, Z ;
Wylezinska, M ;
Taylor, M ;
Jezzard, P ;
Matthews, PM ;
Cowen, PJ .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (02) :368-370
[8]   Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients [J].
Bhagwagar, Zubin ;
Wylezinska, Marzena ;
Jezzard, Peter ;
Evans, John ;
Boorman, Erie ;
Matthews, Paul M. ;
Cowen, Philip J. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (02) :255-260
[9]   Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity [J].
Bigos, Kristin L. ;
Pollock, Bruce G. ;
Aizenstein, Howard J. ;
Fisher, Patrick M. ;
Bies, Robert R. ;
Hariri, Ahmad R. .
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (13) :3221-3225
[10]   GABAergic dysfunction in mood disorders [J].
Brambilla, P ;
Perez, J ;
Barale, F ;
Schettini, G ;
Soares, JC .
MOLECULAR PSYCHIATRY, 2003, 8 (08) :721-737